Status:
ACTIVE_NOT_RECRUITING
To Evaluate add-on Effect of Nisha-Amalaki Tablets Along With Insulin on Glycemic Control in Type 1 Diabetes Patients (RCTNA)
Lead Sponsor:
Hirabai Cowasji Jehangir Medical Research Institute
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
10-18 years
Phase:
NA
Brief Summary
Type-I diabetes mellitus (T1DM) is an autoimmune condition, in which the pancreas reduces/stops insulin production. Patients with T DM have to take insulin injections with every meal and also usually ...
Eligibility Criteria
Inclusion
- K/C/O type-I DM for more than 1 year
- Age above 10 years, (10-18 years) irrespective of sex, religion, and economic status
- Parents provide consent and children providing assent for the study
Exclusion
- K/C/O type-I DM for more than 1 year
- Age above 10 years, (10-18 years) irrespective of sex, religion, and economic status
- Parents provide consent and children providing assent for the study
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06487598
Start Date
July 1 2024
End Date
July 1 2025
Last Update
October 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hirabai Cowasji Jehangir Medical Research Institute
Pune, Maharashtra, India, 411001